John Overdeck’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,754
Closed -$12.2K 5289
2026
Q1
$12.2K Sell
16,754
-23,280
-58% -$21.9K ﹤0.01% 4523
2025
Q4
$39.3K Buy
+40,034
New +$52.9K ﹤0.01% 3958
2025
Q1
Sell
-814
Closed -$7.2K 3382
2024
Q4
$7.2K Buy
+814
New +$8.99K ﹤0.01% 3141
2023
Q2
Sell
-121
Closed -$33.2K 3164
2023
Q1
$33.2K Sell
121
-32
-21% -$13.1K ﹤0.01% 2801
2022
Q4
$45.3K Sell
153
-29
-16% -$9.9K ﹤0.01% 2605
2022
Q3
$64K Sell
182
-104
-36% -$48.2K ﹤0.01% 2290
2022
Q2
$126K Sell
286
-356
-55% -$197K ﹤0.01% 2242
2022
Q1
$486K Sell
642
-321
-33% -$264K ﹤0.01% 2027
2021
Q4
$1.2M Sell
963
-302
-24% -$488K ﹤0.01% 2387
2021
Q3
$2.55M Sell
1,265
-524
-29% -$1.13M 0.01% 1753
2021
Q2
$4.45M Buy
1,789
+1,058
+145% +$2.59M 0.01% 1272
2021
Q1
$1.82M Buy
731
+497
+212% +$1.48M ﹤0.01% 1782
2020
Q4
$664K Sell
234
-240
-51% -$574K ﹤0.01% 2300
2020
Q3
$1.12M Buy
474
+457
+2,688% +$1.13M ﹤0.01% 1677
2020
Q2
$41K Buy
+17
New +$39.7K ﹤0.01% 2848

Other funds holding MBIO

John Overdeck's MBIO Position: Q2 2026 in Review

John Overdeck sold out of Mustang Bio (MBIO) in Q2 2026, closing a stake of 16,754 shares — an estimated $12.2K sold.

John Overdeck first reported a position in MBIO in Q2 2020 and held it in 15 quarters. The position peaked at $4.45M in Q2 2021. 23 funds tracked by Wall St. Rank hold MBIO as of Q2 2026.

  • John Overdeck reported no remaining Mustang Bio position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 16,754 Mustang Bio shares in Q2 2026, an estimated $12.2K.
  • John Overdeck first reported a position in Mustang Bio in Q2 2020 and held it in 15 quarters.
  • John Overdeck's Mustang Bio position peaked at $4.45M in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.